Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13
The constitutively active androgen receptor (AR) splice variant 7 (AR-V7) plays an important role in the progression of castration-resistant prostate cancer (CRPC). Although biomarker studies established the role of AR-V7 in resistance to AR-targeting therapies, how AR-V7 mediates genomic functions...
Gespeichert in:
Veröffentlicht in: | Proceedings of the National Academy of Sciences - PNAS 2018-06, Vol.115 (26), p.6810-6815 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 6815 |
---|---|
container_issue | 26 |
container_start_page | 6810 |
container_title | Proceedings of the National Academy of Sciences - PNAS |
container_volume | 115 |
creator | Chen, Zhong Wu, Dayong Thomas-Ahner, Jennifer M. Lu, Changxue Zhao, Pei Zhang, Qingfu Geraghty, Connor Yan, Pearlly S. Hankey, William Sunkel, Benjamin Cheng, Xiaolong Antonarakis, Emmanuel S. Wang, Qi-En Liu, Zhihua Huang, Tim H.-M. Jin, Victor X. Clinton, Steven K. Luo, Jun Huang, Jiaoti Wang, Qianben |
description | The constitutively active androgen receptor (AR) splice variant 7 (AR-V7) plays an important role in the progression of castration-resistant prostate cancer (CRPC). Although biomarker studies established the role of AR-V7 in resistance to AR-targeting therapies, how AR-V7 mediates genomic functions in CRPC remains largely unknown. Using a ChIP-exo approach, we show AR-V7 binds to distinct genomic regions and recognizes a full-length androgen-responsive element in CRPC cells and patient tissues. Remarkably, we find dramatic differences in AR-V7 cistromes across diverse CRPC cells and patient tissues, regulating different target gene sets involved in CRPC progression. Surprisingly, we discover that HoxB13 is universally required for and colocalizes with AR-V7 binding to open chromatin across CRPC genomes. HoxB13 pioneers AR-V7 binding through direct physical interaction, and collaborates with AR-V7 to up-regulate target oncogenes. Transcriptional coregulation by HoxB13 and AR-V7 was further supported by their coexpression in tumors and circulating tumor cells from CRPC patients. Importantly, HoxB13 silencing significantly decreases CRPC growth through inhibition of AR-V7 oncogenic function. These results identify HoxB13 as a pivotal upstream regulator of AR-V7–driven transcriptomes that are often cell context-dependent in CRPC, suggesting that HoxB13 may serve as a therapeutic target for AR-V7–driven prostate tumors. |
doi_str_mv | 10.1073/pnas.1718811115 |
format | Article |
fullrecord | <record><control><sourceid>jstor_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6042123</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>26510819</jstor_id><sourcerecordid>26510819</sourcerecordid><originalsourceid>FETCH-LOGICAL-c509t-81c7496ec6b3ae27f59181896dafcd88aed6504b857ebd3d138cf1ba1079283d3</originalsourceid><addsrcrecordid>eNpdkc1rFTEUxYNY7Gt17UoZcNPNtPcmmXxshH6oFQqCaLchk7mj83gveSbzpP3vTXm11WaThPPL4dwcxl4jHCNocbKJvhyjRmOwru4ZWyBYbJW08JwtALhujeRynx2UsgQA2xl4wfa5NVKi0gt2fTH9plyoOf3aXusmTGXOaU2lmWITfL34eUqxzVSq4uPcbHKqh5mqGgPlxmdqfqTqEWlo-tvmMt2coXjJ9ka_KvTqfj9k3z9--HZ-2V59-fT5_PSqDR3YuTUYtLSKguqFJ67HzqJBY9XgxzAY42lQHcjedJr6QQwoTBix93V2y40YxCF7v_PdbPs1DYFiTbxymzytfb51yU_ufyVOP12N6xRIjlxUg6N7g5x-banMbj2VQKuVj5S2xXGQmncaFFT03RN0mbY51vEcRwBjuFSyUic7KtSPKpnGhzAI7q4zd9eZe-ysvnj77wwP_N-SKvBmByzLnPKjrjoEg1b8AYUlnKE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2100882464</pqid></control><display><type>article</type><title>Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13</title><source>Jstor Complete Legacy</source><source>MEDLINE</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><creator>Chen, Zhong ; Wu, Dayong ; Thomas-Ahner, Jennifer M. ; Lu, Changxue ; Zhao, Pei ; Zhang, Qingfu ; Geraghty, Connor ; Yan, Pearlly S. ; Hankey, William ; Sunkel, Benjamin ; Cheng, Xiaolong ; Antonarakis, Emmanuel S. ; Wang, Qi-En ; Liu, Zhihua ; Huang, Tim H.-M. ; Jin, Victor X. ; Clinton, Steven K. ; Luo, Jun ; Huang, Jiaoti ; Wang, Qianben</creator><creatorcontrib>Chen, Zhong ; Wu, Dayong ; Thomas-Ahner, Jennifer M. ; Lu, Changxue ; Zhao, Pei ; Zhang, Qingfu ; Geraghty, Connor ; Yan, Pearlly S. ; Hankey, William ; Sunkel, Benjamin ; Cheng, Xiaolong ; Antonarakis, Emmanuel S. ; Wang, Qi-En ; Liu, Zhihua ; Huang, Tim H.-M. ; Jin, Victor X. ; Clinton, Steven K. ; Luo, Jun ; Huang, Jiaoti ; Wang, Qianben</creatorcontrib><description>The constitutively active androgen receptor (AR) splice variant 7 (AR-V7) plays an important role in the progression of castration-resistant prostate cancer (CRPC). Although biomarker studies established the role of AR-V7 in resistance to AR-targeting therapies, how AR-V7 mediates genomic functions in CRPC remains largely unknown. Using a ChIP-exo approach, we show AR-V7 binds to distinct genomic regions and recognizes a full-length androgen-responsive element in CRPC cells and patient tissues. Remarkably, we find dramatic differences in AR-V7 cistromes across diverse CRPC cells and patient tissues, regulating different target gene sets involved in CRPC progression. Surprisingly, we discover that HoxB13 is universally required for and colocalizes with AR-V7 binding to open chromatin across CRPC genomes. HoxB13 pioneers AR-V7 binding through direct physical interaction, and collaborates with AR-V7 to up-regulate target oncogenes. Transcriptional coregulation by HoxB13 and AR-V7 was further supported by their coexpression in tumors and circulating tumor cells from CRPC patients. Importantly, HoxB13 silencing significantly decreases CRPC growth through inhibition of AR-V7 oncogenic function. These results identify HoxB13 as a pivotal upstream regulator of AR-V7–driven transcriptomes that are often cell context-dependent in CRPC, suggesting that HoxB13 may serve as a therapeutic target for AR-V7–driven prostate tumors.</description><identifier>ISSN: 0027-8424</identifier><identifier>EISSN: 1091-6490</identifier><identifier>DOI: 10.1073/pnas.1718811115</identifier><identifier>PMID: 29844167</identifier><language>eng</language><publisher>United States: National Academy of Sciences</publisher><subject>Agricultural production ; Alternative Splicing ; Androgen receptors ; Binding ; Biological Sciences ; Biomarkers ; Castration ; Cell Line, Tumor ; Chromatin ; Environmental impact ; Food security ; Gene Expression Regulation, Neoplastic ; Genomes ; Health ; Homeodomain Proteins - genetics ; Homeodomain Proteins - metabolism ; Humans ; Legumes ; Male ; Neoplasm Proteins - genetics ; Neoplasm Proteins - metabolism ; Prostate cancer ; Prostatic Neoplasms, Castration-Resistant - genetics ; Prostatic Neoplasms, Castration-Resistant - metabolism ; Protein Binding ; Protein Isoforms - biosynthesis ; Protein Isoforms - genetics ; Receptors, Androgen - biosynthesis ; Receptors, Androgen - genetics ; Regulatory sequences ; Therapeutic applications ; Transcription ; Tumor cells ; Tumors ; Up-Regulation ; Vegetables</subject><ispartof>Proceedings of the National Academy of Sciences - PNAS, 2018-06, Vol.115 (26), p.6810-6815</ispartof><rights>Volumes 1–89 and 106–114, copyright as a collective work only; author(s) retains copyright to individual articles</rights><rights>Copyright National Academy of Sciences Jun 26, 2018</rights><rights>2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c509t-81c7496ec6b3ae27f59181896dafcd88aed6504b857ebd3d138cf1ba1079283d3</citedby><cites>FETCH-LOGICAL-c509t-81c7496ec6b3ae27f59181896dafcd88aed6504b857ebd3d138cf1ba1079283d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/26510819$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/26510819$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,723,776,780,799,881,27901,27902,53766,53768,57992,58225</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29844167$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Zhong</creatorcontrib><creatorcontrib>Wu, Dayong</creatorcontrib><creatorcontrib>Thomas-Ahner, Jennifer M.</creatorcontrib><creatorcontrib>Lu, Changxue</creatorcontrib><creatorcontrib>Zhao, Pei</creatorcontrib><creatorcontrib>Zhang, Qingfu</creatorcontrib><creatorcontrib>Geraghty, Connor</creatorcontrib><creatorcontrib>Yan, Pearlly S.</creatorcontrib><creatorcontrib>Hankey, William</creatorcontrib><creatorcontrib>Sunkel, Benjamin</creatorcontrib><creatorcontrib>Cheng, Xiaolong</creatorcontrib><creatorcontrib>Antonarakis, Emmanuel S.</creatorcontrib><creatorcontrib>Wang, Qi-En</creatorcontrib><creatorcontrib>Liu, Zhihua</creatorcontrib><creatorcontrib>Huang, Tim H.-M.</creatorcontrib><creatorcontrib>Jin, Victor X.</creatorcontrib><creatorcontrib>Clinton, Steven K.</creatorcontrib><creatorcontrib>Luo, Jun</creatorcontrib><creatorcontrib>Huang, Jiaoti</creatorcontrib><creatorcontrib>Wang, Qianben</creatorcontrib><title>Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13</title><title>Proceedings of the National Academy of Sciences - PNAS</title><addtitle>Proc Natl Acad Sci U S A</addtitle><description>The constitutively active androgen receptor (AR) splice variant 7 (AR-V7) plays an important role in the progression of castration-resistant prostate cancer (CRPC). Although biomarker studies established the role of AR-V7 in resistance to AR-targeting therapies, how AR-V7 mediates genomic functions in CRPC remains largely unknown. Using a ChIP-exo approach, we show AR-V7 binds to distinct genomic regions and recognizes a full-length androgen-responsive element in CRPC cells and patient tissues. Remarkably, we find dramatic differences in AR-V7 cistromes across diverse CRPC cells and patient tissues, regulating different target gene sets involved in CRPC progression. Surprisingly, we discover that HoxB13 is universally required for and colocalizes with AR-V7 binding to open chromatin across CRPC genomes. HoxB13 pioneers AR-V7 binding through direct physical interaction, and collaborates with AR-V7 to up-regulate target oncogenes. Transcriptional coregulation by HoxB13 and AR-V7 was further supported by their coexpression in tumors and circulating tumor cells from CRPC patients. Importantly, HoxB13 silencing significantly decreases CRPC growth through inhibition of AR-V7 oncogenic function. These results identify HoxB13 as a pivotal upstream regulator of AR-V7–driven transcriptomes that are often cell context-dependent in CRPC, suggesting that HoxB13 may serve as a therapeutic target for AR-V7–driven prostate tumors.</description><subject>Agricultural production</subject><subject>Alternative Splicing</subject><subject>Androgen receptors</subject><subject>Binding</subject><subject>Biological Sciences</subject><subject>Biomarkers</subject><subject>Castration</subject><subject>Cell Line, Tumor</subject><subject>Chromatin</subject><subject>Environmental impact</subject><subject>Food security</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Genomes</subject><subject>Health</subject><subject>Homeodomain Proteins - genetics</subject><subject>Homeodomain Proteins - metabolism</subject><subject>Humans</subject><subject>Legumes</subject><subject>Male</subject><subject>Neoplasm Proteins - genetics</subject><subject>Neoplasm Proteins - metabolism</subject><subject>Prostate cancer</subject><subject>Prostatic Neoplasms, Castration-Resistant - genetics</subject><subject>Prostatic Neoplasms, Castration-Resistant - metabolism</subject><subject>Protein Binding</subject><subject>Protein Isoforms - biosynthesis</subject><subject>Protein Isoforms - genetics</subject><subject>Receptors, Androgen - biosynthesis</subject><subject>Receptors, Androgen - genetics</subject><subject>Regulatory sequences</subject><subject>Therapeutic applications</subject><subject>Transcription</subject><subject>Tumor cells</subject><subject>Tumors</subject><subject>Up-Regulation</subject><subject>Vegetables</subject><issn>0027-8424</issn><issn>1091-6490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkc1rFTEUxYNY7Gt17UoZcNPNtPcmmXxshH6oFQqCaLchk7mj83gveSbzpP3vTXm11WaThPPL4dwcxl4jHCNocbKJvhyjRmOwru4ZWyBYbJW08JwtALhujeRynx2UsgQA2xl4wfa5NVKi0gt2fTH9plyoOf3aXusmTGXOaU2lmWITfL34eUqxzVSq4uPcbHKqh5mqGgPlxmdqfqTqEWlo-tvmMt2coXjJ9ka_KvTqfj9k3z9--HZ-2V59-fT5_PSqDR3YuTUYtLSKguqFJ67HzqJBY9XgxzAY42lQHcjedJr6QQwoTBix93V2y40YxCF7v_PdbPs1DYFiTbxymzytfb51yU_ufyVOP12N6xRIjlxUg6N7g5x-banMbj2VQKuVj5S2xXGQmncaFFT03RN0mbY51vEcRwBjuFSyUic7KtSPKpnGhzAI7q4zd9eZe-ysvnj77wwP_N-SKvBmByzLnPKjrjoEg1b8AYUlnKE</recordid><startdate>20180626</startdate><enddate>20180626</enddate><creator>Chen, Zhong</creator><creator>Wu, Dayong</creator><creator>Thomas-Ahner, Jennifer M.</creator><creator>Lu, Changxue</creator><creator>Zhao, Pei</creator><creator>Zhang, Qingfu</creator><creator>Geraghty, Connor</creator><creator>Yan, Pearlly S.</creator><creator>Hankey, William</creator><creator>Sunkel, Benjamin</creator><creator>Cheng, Xiaolong</creator><creator>Antonarakis, Emmanuel S.</creator><creator>Wang, Qi-En</creator><creator>Liu, Zhihua</creator><creator>Huang, Tim H.-M.</creator><creator>Jin, Victor X.</creator><creator>Clinton, Steven K.</creator><creator>Luo, Jun</creator><creator>Huang, Jiaoti</creator><creator>Wang, Qianben</creator><general>National Academy of Sciences</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20180626</creationdate><title>Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13</title><author>Chen, Zhong ; Wu, Dayong ; Thomas-Ahner, Jennifer M. ; Lu, Changxue ; Zhao, Pei ; Zhang, Qingfu ; Geraghty, Connor ; Yan, Pearlly S. ; Hankey, William ; Sunkel, Benjamin ; Cheng, Xiaolong ; Antonarakis, Emmanuel S. ; Wang, Qi-En ; Liu, Zhihua ; Huang, Tim H.-M. ; Jin, Victor X. ; Clinton, Steven K. ; Luo, Jun ; Huang, Jiaoti ; Wang, Qianben</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c509t-81c7496ec6b3ae27f59181896dafcd88aed6504b857ebd3d138cf1ba1079283d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Agricultural production</topic><topic>Alternative Splicing</topic><topic>Androgen receptors</topic><topic>Binding</topic><topic>Biological Sciences</topic><topic>Biomarkers</topic><topic>Castration</topic><topic>Cell Line, Tumor</topic><topic>Chromatin</topic><topic>Environmental impact</topic><topic>Food security</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Genomes</topic><topic>Health</topic><topic>Homeodomain Proteins - genetics</topic><topic>Homeodomain Proteins - metabolism</topic><topic>Humans</topic><topic>Legumes</topic><topic>Male</topic><topic>Neoplasm Proteins - genetics</topic><topic>Neoplasm Proteins - metabolism</topic><topic>Prostate cancer</topic><topic>Prostatic Neoplasms, Castration-Resistant - genetics</topic><topic>Prostatic Neoplasms, Castration-Resistant - metabolism</topic><topic>Protein Binding</topic><topic>Protein Isoforms - biosynthesis</topic><topic>Protein Isoforms - genetics</topic><topic>Receptors, Androgen - biosynthesis</topic><topic>Receptors, Androgen - genetics</topic><topic>Regulatory sequences</topic><topic>Therapeutic applications</topic><topic>Transcription</topic><topic>Tumor cells</topic><topic>Tumors</topic><topic>Up-Regulation</topic><topic>Vegetables</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Zhong</creatorcontrib><creatorcontrib>Wu, Dayong</creatorcontrib><creatorcontrib>Thomas-Ahner, Jennifer M.</creatorcontrib><creatorcontrib>Lu, Changxue</creatorcontrib><creatorcontrib>Zhao, Pei</creatorcontrib><creatorcontrib>Zhang, Qingfu</creatorcontrib><creatorcontrib>Geraghty, Connor</creatorcontrib><creatorcontrib>Yan, Pearlly S.</creatorcontrib><creatorcontrib>Hankey, William</creatorcontrib><creatorcontrib>Sunkel, Benjamin</creatorcontrib><creatorcontrib>Cheng, Xiaolong</creatorcontrib><creatorcontrib>Antonarakis, Emmanuel S.</creatorcontrib><creatorcontrib>Wang, Qi-En</creatorcontrib><creatorcontrib>Liu, Zhihua</creatorcontrib><creatorcontrib>Huang, Tim H.-M.</creatorcontrib><creatorcontrib>Jin, Victor X.</creatorcontrib><creatorcontrib>Clinton, Steven K.</creatorcontrib><creatorcontrib>Luo, Jun</creatorcontrib><creatorcontrib>Huang, Jiaoti</creatorcontrib><creatorcontrib>Wang, Qianben</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Zhong</au><au>Wu, Dayong</au><au>Thomas-Ahner, Jennifer M.</au><au>Lu, Changxue</au><au>Zhao, Pei</au><au>Zhang, Qingfu</au><au>Geraghty, Connor</au><au>Yan, Pearlly S.</au><au>Hankey, William</au><au>Sunkel, Benjamin</au><au>Cheng, Xiaolong</au><au>Antonarakis, Emmanuel S.</au><au>Wang, Qi-En</au><au>Liu, Zhihua</au><au>Huang, Tim H.-M.</au><au>Jin, Victor X.</au><au>Clinton, Steven K.</au><au>Luo, Jun</au><au>Huang, Jiaoti</au><au>Wang, Qianben</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13</atitle><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle><addtitle>Proc Natl Acad Sci U S A</addtitle><date>2018-06-26</date><risdate>2018</risdate><volume>115</volume><issue>26</issue><spage>6810</spage><epage>6815</epage><pages>6810-6815</pages><issn>0027-8424</issn><eissn>1091-6490</eissn><abstract>The constitutively active androgen receptor (AR) splice variant 7 (AR-V7) plays an important role in the progression of castration-resistant prostate cancer (CRPC). Although biomarker studies established the role of AR-V7 in resistance to AR-targeting therapies, how AR-V7 mediates genomic functions in CRPC remains largely unknown. Using a ChIP-exo approach, we show AR-V7 binds to distinct genomic regions and recognizes a full-length androgen-responsive element in CRPC cells and patient tissues. Remarkably, we find dramatic differences in AR-V7 cistromes across diverse CRPC cells and patient tissues, regulating different target gene sets involved in CRPC progression. Surprisingly, we discover that HoxB13 is universally required for and colocalizes with AR-V7 binding to open chromatin across CRPC genomes. HoxB13 pioneers AR-V7 binding through direct physical interaction, and collaborates with AR-V7 to up-regulate target oncogenes. Transcriptional coregulation by HoxB13 and AR-V7 was further supported by their coexpression in tumors and circulating tumor cells from CRPC patients. Importantly, HoxB13 silencing significantly decreases CRPC growth through inhibition of AR-V7 oncogenic function. These results identify HoxB13 as a pivotal upstream regulator of AR-V7–driven transcriptomes that are often cell context-dependent in CRPC, suggesting that HoxB13 may serve as a therapeutic target for AR-V7–driven prostate tumors.</abstract><cop>United States</cop><pub>National Academy of Sciences</pub><pmid>29844167</pmid><doi>10.1073/pnas.1718811115</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0027-8424 |
ispartof | Proceedings of the National Academy of Sciences - PNAS, 2018-06, Vol.115 (26), p.6810-6815 |
issn | 0027-8424 1091-6490 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6042123 |
source | Jstor Complete Legacy; MEDLINE; PubMed Central; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry |
subjects | Agricultural production Alternative Splicing Androgen receptors Binding Biological Sciences Biomarkers Castration Cell Line, Tumor Chromatin Environmental impact Food security Gene Expression Regulation, Neoplastic Genomes Health Homeodomain Proteins - genetics Homeodomain Proteins - metabolism Humans Legumes Male Neoplasm Proteins - genetics Neoplasm Proteins - metabolism Prostate cancer Prostatic Neoplasms, Castration-Resistant - genetics Prostatic Neoplasms, Castration-Resistant - metabolism Protein Binding Protein Isoforms - biosynthesis Protein Isoforms - genetics Receptors, Androgen - biosynthesis Receptors, Androgen - genetics Regulatory sequences Therapeutic applications Transcription Tumor cells Tumors Up-Regulation Vegetables |
title | Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T14%3A03%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diverse%20AR-V7%20cistromes%20in%20castration-resistant%20prostate%20cancer%20are%20governed%20by%20HoxB13&rft.jtitle=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20-%20PNAS&rft.au=Chen,%20Zhong&rft.date=2018-06-26&rft.volume=115&rft.issue=26&rft.spage=6810&rft.epage=6815&rft.pages=6810-6815&rft.issn=0027-8424&rft.eissn=1091-6490&rft_id=info:doi/10.1073/pnas.1718811115&rft_dat=%3Cjstor_pubme%3E26510819%3C/jstor_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2100882464&rft_id=info:pmid/29844167&rft_jstor_id=26510819&rfr_iscdi=true |